Uso de antibióticos inhalados para el tratamiento de infecciones por bacterias multirresistentes en pacientes críticamente enfermos: una revisión de literatura reciente

Dr. José Pablo Díaz Madriz
Farmacéutico, Hospital Clínica Bíblica, San José, Costa Rica.
Miembro del Colegio de Farmacéuticos de Costa Rica.
Costa Rica.

Dr. Jonathan Rojas Rodríguez
Farmacéutico, Hospital San Juan de Dios, San José, Costa Rica.
Miembro del Colegio de Farmacéuticos de Costa Rica.
Costa Rica.

Dr. Jorge Arturo Villalobos Madriz
Médico interno, Escuela de Medicina, UCIMED, San José, Costa Rica.
Miembro del Colegio de Médicos y Cirujanos de Costa Rica.
Costa Rica.

Resumen

La administración de antibióticos por vía nebulizada es utilizada principalmente para el tratamiento de pacientes con fibrosis quística. Sin embargo, debido al incremento en la resistencia bacteriana, esta vía de administración se ha convertido en una opción cada vez más utilizada para pacientes críticamente enfermos por infecciones por patógenos multirresistentes, aunque la información respecto a su uso no es del todo clara.

Palabras claves

Antibióticos, inhalados, nebulizados, en aerosol, neumonía asociada al ventilador.

Abstract

The administration of inhaled antibiotics is used primarily for the treatment of patients with cystic fibrosis. However, due to an increased bacterial resistance, this route of administration has become an option increasingly used for critically ill patients from infection by multiresistant pathogens, although information regarding their use is not entirely clear.

Keywords

Antibiotics, inhaled, nebulized, aerosolized, Ventilator associated pneumonia (VAP).

Bibliografía

Burchett, D.; Darko, W.; Zahra, J.; Noviasky, J.; Probst, L. & Smith, A. (2010) Mixing and compatibility guide for commonly used aerosolized medications. Am J Health-Syst Pharm, 67: 227-230.

Collins, N. (2009) Nebulizer therapy in cystic fibrosis: an overview. J R Soc Med, 102:11–17.

Czosnowski, Q.; Wood, C.; Magnotti, L.; Croce, M.; Swanson, J.; Boucher, B. et al. (2009) Adjunctive Aerosolized Antibiotics for Treatment of Ventilator-Associated Pneumonia. Pharmacotherpy, 29(9):1054–1060.

Dellit, T.; Owens, R.; McGowan, J.; Gerding, D.; Weinstein, R.; Burke, J. et al. (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship. Clin Infect Dis, 44(2):159-177.

Ehrmann, S.; Roche-Campo, F.; Sferrazza, P.; Isabey, D.; Brochard, L. & Apiou-Sbirlea, G. (2013) Aerosol therapy during mechanical ventilation: an international survey 2013, Intensive Care Med; 39:1048–1056.

Falagas, M.; Kasiakou, S.; Tsiodras, S. & Michalopoulos, A. (2006) The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically Ill Patients: A Review of the Recent Literature. Clin Med Res, 4(2): 138-146.

Falagas, M.; Kyriakos, K. & Konstantinos, Z. (2015) Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review. Int J Antimicrob, 45: 221-233.

Florescu, D.; Qiu, F.; McCartan, M.; Mindru, C.; Fey, F. & Kalil, C. (2012) What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression. Clin Infect Dis; 54(5):670-680.

Gaspar, M.; Couet, W. & Olivier, J. (2013) Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review. Eur J Clin Microbiol Infect Dis, 32:1231–1252.

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. (2005) Am J Resp Crit Care, 171: (4)388-416.

Gu, W.; Wang, F.; Tang, L.; Bakker, J. & Liu, J. (2014) Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: A systematic review and meta-analysis. Int J Antimicrob; 44: 477-485.

Gurjar, M. (2015) Colistin for lung infection: an update. Journal of Intensive Care, 3:3.

Ioannidou, E.; Siempos, I. & Falagas, M. (2007) Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J Antimicrob Chemoth, 60:1216–1226.

Islam, N. & Rahman, S. (2008) Pulmonary drug delivery: Implication for new strategy for pharmacotherapy for neurodegenerative disorders. Drug Discov Ther, 2(5):264-276.

Kaki, R.; Elligsen, M.; Walker, S.; Simor, A.; Palmay, L. & Daneman, N. (2011) Impact of antimicrobial stewardship in critical care: A systematic review. J Antimicrob Chemother, 66(6):1223–1230.

Kollef, M.; Hamilton, C. & Montgomery, B. (2013) Aerosolized antibiotics: do they add to the treatment of pneumonia? Curr Opin Infect Dis, 26:538–544.

Le, J.; Dodds, E.; Neuhaser, M.; Brown, J.; Gentry, C.; Klepser, M.; Marr, A. et al. (2010) Consensus Summary of Aerosolized Antimicrobial Agents: Application of Guideline Criteria. Pharmacotherapy, 30(6): 562-584.

Matthaiou, D.; Waele, J. & Dimopoulos, G. (2014) What is new in the use of aminoglycosides in critically ill patients? Intens Care Med, 40: 1553-1555.

Michalopoulos, A. & Falagas, M. (2014) Inhaled antibiotics in mechanically ventilated patients. Minerva Anestesiol; 80:236-44.

Lu, Q.; Yang, J.; Liu, Z.; Gutiérrez, C.; Aymard, G. & Rouby, J. (2011) Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med; 184:106–115.

Murray, M.; Govan, J.; Doherty, C.; Simpson, J.; Wilkinson, T.; Chalmers, J. et al. (2011) A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis. Am J Respir Crit Care Med, 183. (491–499).

Nation, R.; Li, J.; Cars, O.; Couet, W.; Dudley, M.; Kaye, K. et al. (2015) Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. Lancet Infect Dis; 15: 225-243.

Olveira, C.; Muñoz, A. & Domenech, A. (2014) Nebulized Therapy. SEPAR Year. Arch Bronconeumol, 50(12):535-545.

Palmer, L. & Smaldone, G. (2014) Reduction of Bacterial Resistance with Inhaled Antibiotics in the Intensive Care Unit. Am J Respir Crit Care Med, 189(10): 1225–1233.


Palmer, L.; Smaldone, G.; Chen, J.; Baram, D.; Duan, T.; Monteforte, M. et al. (2008) Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med, 36(7): 2008-2013.

Quon, B.; Goss, C. & Ramsey, B. (2014) Inhaled Antibiotics for Lower Airway Infections. Ann Am Thorac Soc; 11(3):425–434.

Rattanaumpawan, P.; Lorsutthitham, J.; Ungprasert, P.; Nasikarn, A. & Thamlikitkul, V. (2010) Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria. J Antimicrob Chemother; 65: 2645–2649.

Roberts, J.; Abdul-Aziz, M.; Lipman, J.; Mouton, J.; Vinks, A.; Felton, T. et al. (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis, 14: 498–509.

Segura, S. & Brenes, M. (2014) Actualidades en terapéutica: Nuevos Antibacterianos. Rev Med UCR, 8 (1):49-69.

Trevino, S. & Kollef, M. (2015) Management of
 Infections with Drug-Resistant Organisms in Critical Care: An Ongoing Battle. Clin Chest Med. 36 531–541.

Tumbarello, M.; Pascale, G.; Trecarichi, E.; De Martino, S.; Bello, G.; Maviglia, R. et al. (2013) Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria. CHEST; 144(6):1768–1775.

Valachis, A.; Samonis, G. & Kofteridis, D.P. (2014) The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: a systematic review and metaanalysis. Crit Care Med.

Watts, A.; McConville, J. & Williams, R. (2008) Current Therapies and Technological Advances in Aqueous Aerosol Drug Delivery. Drug Dev Ind Pharm, 34:913–922.

Willis, L.; Hayes, D. & Mansour, H. (2012) Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery. Lung, 190:251–262.

Zampieri, F.; Nassar, A.; Gusmao-Flores, D.; Taniguchi, L.; Torres, A. & Ranzani O. (2015) Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis. Critical Care, 19:150-162.